New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 15, 2013
10:12 EDTHNZ, NTGR, KGC, VAL, PDS, GNRC, NGLS, XL, ATML, PSUN, SGNT, QLIK, EAT, KFY, SAAS, QEPOn the Fly: Analyst Upgrade Summary
Today’s noteworthy upgrades include: Heinz (HNZ) upgraded to Neutral from Sell at Goldman... inContact (SAAS) upgraded to Buy from Neutral at Roth Capital... Korn/Ferry (KFY) upgraded to Buy from Neutral at SunTrust... Qlik Technologies (QLIK) upgraded to Outperform from Sector Perform at RBC Capital... XL Group (XL) upgraded to Buy from Neutral at Janney Capital... Brinker (EAT) upgraded to Buy from Neutral at Davenport... Sagent Pharmaceuticals (SGNT) upgraded to Overweight from Neutral at Piper Jaffray... Atmel (ATML) upgraded to Buy from Hold at Craig-Hallum... Qlik Technologies (QLIK) upgraded to Positive from Neutral at Susquehanna... Pacific Sunwear (PSUN) upgraded to Buy from Neutral at DA Davidson... Targa Resources Partners (NGLS) upgraded to Buy from Hold at Stifel Nicolaus... Generac (GNRC) upgraded to Buy from Hold at Stifel Nicolaus... Precision Drilling (PDS) upgraded to Outperform from Market Perform at Raymond James... Valspar (VAL) upgraded to Overweight from Equal Weight at First Analysis... Kinross Gold (KGC) upgraded to Outperform from Neutral at Credit Suisse... QEP Resources (QEP) upgraded to Neutral from Underperform at Sterne Agee... Netgear (NTGR) upgraded to Buy from Neutral at Sterne Agee
News For HNZ;SAAS;KFY;EAT;QLIK;SGNT;PSUN;ATML;XL;NGLS;GNRC;PDS;VAL;KGC;NTGR;QEP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 26, 2014
13:43 EDTSGNTSagent Pharmaceuticals launches GLYDO
Sagent Pharmaceuticals announced the launch of GLYDO. GLYDO is a topical urological anesthetic lubricant available in prefilled, ready-to-use, disposable plastic syringes in two unique sizes, 6 mL and 11 mL. GLYDO syringes are individually packaged and sterilized, allowing GLYDO to be used during surgical procedures while maintaining the integrity of the sterile field.
07:14 EDTSAASinContact outlook positive, says Oppenheimer
Subscribe for More Information
September 25, 2014
12:17 EDTVALH.B. Fuller plummets to 52-week low after results, outlook trail estimates
Shares of H.B. Fuller (FUL), which manufactures adhesives, sealants and other specialty chemical products, are sinking after the company's third quarter results and fourth quarter profit outlook missed analysts' consensus estimates. WHAT'S NEW: Last night, H.B. Fuller reported Q3 adjusted earnings per share of 42c and revenue of $526.8M, significantly trailing analysts' consensus estimates of 76c and $539.54M, respectively. The company forecast Q4 adjusted EPS of 60c-70c, far below the consensus of 85c. H.B. Fuller increased its fiscal year 2014 CapEx view to $135M from $105M. WHAT'S NOTABLE: H.B. Fuller CEO Jim Owens said, "The delayed and costly execution of our SAP project in North America and European business integration project led to disappointing and unacceptable results this quarter. We took decisive actions to accelerate the completion of our major projects and move to normal operating conditions. More work is to be done in the fourth quarter, but we expect our intensified focus on completing these projects will lead to improved operating performance in the fourth quarter and pave the way for a strong 2015, putting us back on track to achieve our long term goals of 15% EBITDA margin and solid organic growth." On its conference call, management confirmed the 15% EBITDA margin goal, but said it will be delayed at least one year. They expect "significant" improvements in Q4, and FY15, and noted that recent challenges have been project related and can easily be fixed. They expect to launch the Latin America business in mid-2015. PRICE ACTION: In early afternoon trading, H.B. Fuller fell $5.44, or about 12.37%, to $38.54 on over seven times its average daily trading volume. Earlier in the session, the stock notched a fresh 52-week low of $36.92. Including today's pull-back, the shares have lost almost 5% over the past 12 months. OTHERS TO WATCH: Other companies in the sealants and chemicals space include Sherwin-Williams (SHW), The Valspar Corporation (VAL), and RPM International (RPM).
10:06 EDTKFYOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 58.com (WUBA) initiated with a Neutral at Goldman... Auspex Pharmaceuticals (ASPX) initiated with a Buy at Ladenburg... Finjan Holdings (FNJN) initiated with a Buy at H.C. Wainwright... JD.com (JD) initiated with an Outperform at Macquarie... Korn/Ferry (KFY) initiated with a Neutral at Piper Jaffray... Manpower (MAN) initiated with an Overweight at Piper Jaffray... On Assignment (ASGN) initiated with an Overweight at Piper Jaffray... Robert Half (RHI) initiated with a Neutral at Piper Jaffray... Towers Watson (TW) initiated with an Overweight at Piper Jaffray.
September 24, 2014
16:12 EDTKFYKorn/Ferry initiated with a Neutral at Piper Jaffray
Target $30.
07:56 EDTKGCCFA Society of Philadelphia to host a luncheon meeting
Subscribe for More Information
September 23, 2014
16:07 EDTSGNTSagent Pharmaceuticals announces introduction of Oxaliplatin Injection, USP
Sagent Pharmaceuticals announced the introduction of Oxaliplatin Injection, USP, an antineoplastic agent, now in two liquid presentations. According to IMS, for the 12 months ending July 2014, the US market for Oxaliplatin approximated $102M. As with all products in Sagent's portfolio, Oxaliplatin features Sagent's PreventIV Measures packaging and labeling, designed to help reduce the risk of medication errors.
07:54 EDTSGNTLeerink to hold a conference
Subscribe for More Information
September 17, 2014
16:32 EDTSGNTSagent Pharmaceuticals announces launch of Ketorolac Tromethamine Injection
Subscribe for More Information
07:02 EDTQLIKQlik Technologies licensing growth poised to accelerate, says Pacific Crest
Subscribe for More Information
September 16, 2014
10:33 EDTQEPHigh option volume stocks
Subscribe for More Information
07:41 EDTKGCDenver Gold Group to hold a forum
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use